Researchers ‘stunned’ to find approved cholesterol drug has negligible effect
May 31, 2011
The National Institutes of Health announced it is ending its study of the cholesterol drug Niaspan 18 months early. Tracking results showed the medication had almost no chance of being beneficial to patients,...
AHRQ gives $34 million to nursing homes, other settings to fight healthcare-associated infections
Nov 05, 2010
The Health and Human Service’s Agency for Healthcare Research and Quality said it will be giving $34 million to projects working to prevent healthcare-associated infections in long-term care facilities,...
Fauci: ‘Pan-viral’ vaccine may be needed to tackle tenacious COVID-19 long-term
By
Alicia Lasek
Feb 16, 2021
The virus that causes COVID-19 likely is here to stay, and its success in humans means that stronger defense measures will be needed, say Anthony Fauci, M.D., and colleagues from the National Institute...
Feds race to buy COVID antibody cocktails
By
Alicia Lasek
Oct 14, 2020
The federal government is planning to stockpile COVID-19 antibody drugs in an effort to ensure treatment availability while the country awaits a vaccine.